JP2019048895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019048895A5 JP2019048895A5 JP2018246722A JP2018246722A JP2019048895A5 JP 2019048895 A5 JP2019048895 A5 JP 2019048895A5 JP 2018246722 A JP2018246722 A JP 2018246722A JP 2018246722 A JP2018246722 A JP 2018246722A JP 2019048895 A5 JP2019048895 A5 JP 2019048895A5
- Authority
- JP
- Japan
- Prior art keywords
- citrullinated
- antibody
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361894042P | 2013-10-22 | 2013-10-22 | |
| US61/894,042 | 2013-10-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016525584A Division JP2016539925A (ja) | 2013-10-22 | 2014-10-22 | Ｔｌｒ４リガンドまたは他のバイオマーカーのレベルが上昇した患者における障害の診断および処置を行うための方法および組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020177986A Division JP2021006592A (ja) | 2013-10-22 | 2020-10-23 | Ｔｌｒ４リガンドまたは他のバイオマーカーのレベルが上昇した患者における障害の診断および処置を行うための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019048895A JP2019048895A (ja) | 2019-03-28 |
| JP2019048895A5 true JP2019048895A5 (enExample) | 2019-09-12 |
Family
ID=51866128
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016525584A Pending JP2016539925A (ja) | 2013-10-22 | 2014-10-22 | Ｔｌｒ４リガンドまたは他のバイオマーカーのレベルが上昇した患者における障害の診断および処置を行うための方法および組成物 |
| JP2018246722A Withdrawn JP2019048895A (ja) | 2013-10-22 | 2018-12-28 | Ｔｌｒ４リガンドまたは他のバイオマーカーのレベルが上昇した患者における障害の診断および処置を行うための方法および組成物 |
| JP2020177986A Pending JP2021006592A (ja) | 2013-10-22 | 2020-10-23 | Ｔｌｒ４リガンドまたは他のバイオマーカーのレベルが上昇した患者における障害の診断および処置を行うための方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016525584A Pending JP2016539925A (ja) | 2013-10-22 | 2014-10-22 | Ｔｌｒ４リガンドまたは他のバイオマーカーのレベルが上昇した患者における障害の診断および処置を行うための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020177986A Pending JP2021006592A (ja) | 2013-10-22 | 2020-10-23 | Ｔｌｒ４リガンドまたは他のバイオマーカーのレベルが上昇した患者における障害の診断および処置を行うための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9688769B2 (enExample) |
| EP (1) | EP3060250A1 (enExample) |
| JP (3) | JP2016539925A (enExample) |
| CN (1) | CN105899231A (enExample) |
| AU (2) | AU2014338991B2 (enExample) |
| CA (1) | CA2928317A1 (enExample) |
| WO (1) | WO2015059168A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE037613T2 (hu) * | 2012-03-29 | 2018-09-28 | Novimmune Sa | Anti-TLR4 antitestek és azok felhasználása |
| EP3060250A1 (en) | 2013-10-22 | 2016-08-31 | NovImmune SA | Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of tlr4 ligands and other biomarkers |
| WO2017021552A1 (en) * | 2015-08-06 | 2017-02-09 | Novimmune Sa | Methods and compositions for identifying patient populations for diagnosis and treatment of tlr4-dependent disorders |
| WO2018065300A1 (en) * | 2016-10-04 | 2018-04-12 | F. Hoffmann-La Roche Ag | System and method for identification of a synthetic classifier |
| EP3580571B1 (en) | 2017-02-07 | 2023-06-07 | Lyfstone B.V. | Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening |
| WO2020225549A1 (en) * | 2019-05-06 | 2020-11-12 | The Francis Crick Institute Limited | Method for preventing inflammation |
| JP7807372B2 (ja) * | 2019-12-20 | 2026-01-27 | ハドソン インスティチュート オブ メディカル リサーチ | Ｃｘｃｌ１０結合タンパク質及びその使用 |
| WO2021212222A1 (en) * | 2020-04-20 | 2021-10-28 | Edesa Biotech Research Inc. | Compositions and methods for treatment of acute respiratory distress syndrome |
| CN113358872B (zh) * | 2021-06-03 | 2022-10-21 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 用于评估肿瘤免疫治疗疗效的标志物组及系统 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US7674884B2 (en) * | 2003-12-10 | 2010-03-09 | Novimmune S.A. | Neutralizing antibodies and methods of use thereof |
| ATE544783T1 (de) * | 2003-12-10 | 2012-02-15 | Novimmune Sa | Neutralisierende anti tlr4/md-2 antikörper und verfahren zu deren verwendung |
| US7312320B2 (en) | 2003-12-10 | 2007-12-25 | Novimmune Sa | Neutralizing antibodies and methods of use thereof |
| AU2005272598B2 (en) | 2004-08-12 | 2011-11-17 | Helsinn Therapeutics (U.S.), Inc. | Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues |
| DE602005021694D1 (de) * | 2004-12-10 | 2010-07-15 | Novimmune Sa | Kombinationstherapien gegen multiple toll-like-rezeptoren und ihre verwendung |
| KR101379693B1 (ko) | 2005-08-25 | 2014-04-10 | 크리어빌리스 쎄라퓨틱스 에스.피.에이. | Ｋ-252ａ 및 그의 유도체의 중합체 컨쥬게이트 |
| CN101248105B (zh) * | 2005-08-25 | 2012-10-10 | 克雷毕里斯治疗股份公司 | K-252a及其衍生物的聚合物缀合物 |
| US20070148704A1 (en) | 2005-10-06 | 2007-06-28 | Ursula Klause | Anti-CCPand antinuclear antibodies in diagnosis of rheumatoid arthritis |
| US7712333B2 (en) | 2006-03-29 | 2010-05-11 | Asahi Glass Company, Limited | Method for smoothing a surface of a glass substrate for a reflective mask blank used in EUV lithography |
| SI2173381T1 (sl) * | 2007-05-14 | 2014-01-31 | Novimmune Sa | Fc receptor-vezavni polipeptidi z modificiranimi efektorskimi funkcijami |
| CN101589491B (zh) | 2007-07-24 | 2011-07-27 | 松下电器产业株式会社 | 镍氢电池用负极材料及其处理方法以及镍氢电池 |
| WO2009138494A2 (en) | 2008-05-15 | 2009-11-19 | Ablynx N.V. | Amino acid sequences directed against toll-like receptors and polypeptides comprising the same for the treatment of diseases related to toll-like receptors |
| US9140701B2 (en) * | 2009-08-18 | 2015-09-22 | The Board Of Trustees Of The Leland Stanford Junior University | Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritis |
| AU2011325134B2 (en) | 2010-11-05 | 2014-10-23 | Novartis Ag | Methods of treating rheumatoid arthritis using IL-17 antagonists |
| JP6289098B2 (ja) * | 2011-01-10 | 2018-03-07 | ノビミューン エスアー | 抗ｔｌｒ４抗体およびその使用法 |
| US20140378531A1 (en) * | 2012-02-01 | 2014-12-25 | New York University | Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors |
| WO2015010791A2 (en) | 2013-07-24 | 2015-01-29 | Klareskog, Lars | Novel antibodies for the diagnosis and treatment of rheumatoid arthritis |
| EP3060250A1 (en) | 2013-10-22 | 2016-08-31 | NovImmune SA | Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of tlr4 ligands and other biomarkers |
-
2014
- 2014-10-22 EP EP14793805.4A patent/EP3060250A1/en not_active Withdrawn
- 2014-10-22 AU AU2014338991A patent/AU2014338991B2/en not_active Ceased
- 2014-10-22 CA CA2928317A patent/CA2928317A1/en not_active Abandoned
- 2014-10-22 JP JP2016525584A patent/JP2016539925A/ja active Pending
- 2014-10-22 US US14/520,904 patent/US9688769B2/en active Active
- 2014-10-22 WO PCT/EP2014/072606 patent/WO2015059168A1/en not_active Ceased
- 2014-10-22 CN CN201480070143.8A patent/CN105899231A/zh active Pending
-
2017
- 2017-06-26 US US15/632,882 patent/US10556960B2/en active Active
-
2018
- 2018-12-28 JP JP2018246722A patent/JP2019048895A/ja not_active Withdrawn
-
2020
- 2020-09-11 AU AU2020230333A patent/AU2020230333A1/en not_active Abandoned
- 2020-10-23 JP JP2020177986A patent/JP2021006592A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10774154B2 (en) | Complex-specific antibodies and antibody fragments and its use | |
| JP2020522261A5 (enExample) | ||
| Aletaha et al. | Therapeutic implications of autoantibodies in rheumatoid arthritis | |
| JP2016539925A5 (enExample) | ||
| ES2989669T3 (es) | Anticuerpos monoclonales inmunoestimuladores contra interleucina 2 humana | |
| US10590188B2 (en) | Antibody | |
| IL273196B2 (en) | Claudin6 antibodies and methods of treating cancer | |
| US20170081402A1 (en) | Methods of treating inflammatory diseases | |
| JP2012012402A5 (enExample) | ||
| RU2011149334A (ru) | Анти-il-17f антитела и способы их применения | |
| JP2017523984A5 (enExample) | ||
| JP2018535922A (ja) | 抗Ｎ−メチル−Ｄ−アスパラギン酸（ＮＭＤＡ）受容体抗体の結合領域に結合する抗体または抗体フラグメントまたは非Ｉｇ足場 | |
| JP7331168B2 (ja) | 多発性骨髄腫におけるｍタンパク質反応の臨床評価 | |
| JP2023518225A5 (enExample) | ||
| CN112703204B (zh) | 针对可溶性bcma的抗体 | |
| CN116554323A (zh) | 人源化抗il21抗体的开发和应用 | |
| CN117069848B (zh) | 抗人cd146兔单克隆抗体及其应用 | |
| RU2016106708A (ru) | Лекарственное средство, содержащее антитело к фосфолипазе d4 | |
| US20100196402A1 (en) | Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody | |
| JP2022501389A5 (enExample) | ||
| US20100204059A1 (en) | CDR-Anchored Amplification Method | |
| EP3519820A1 (en) | Spr-based dual-binding assay for the functional analysis of multispecific molecules | |
| JP2020515286A5 (enExample) | ||
| Sadeghian-Rizi et al. | Production of novel camelid anti-CXCL10 specific polyclonal antibodies and evaluation of their bioreactivity | |
| CN115335402B (zh) | 特异性抗原结合分子,其制备方法及医药用途 |